Mylan (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE™ (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day), the ...

Pharmaceutical firm Mylan is dramatically expanding a nationwide recall of some blood pressure medications after detecting trace amounts of a chemical linked to cancer. The recalled products all ...

Mylan CEO Heather Bresch survived an ouster attempt by angry shareholders. Heather Bresch is willing to participate in a high-profile industry conference this week, but not testify before Congress — ...

After weeks of controversy, the Centers for Medicare and Medicaid Services formally blamed Mylan Pharmaceuticals for misclassifying EpiPen with the Medicaid Drug Rebate Program. Under the program, ...

The deal sparked some early confusion over the price tag. Initial coverage from Crain's Chicago Business reported an $82.5 ...

Source: Teva Pharmaceutical via Facebook. What: Shares of Mylan, a branded-drug developer that is alsoa large player in the generic drug market, surged by 22% in April, according to data from S&P ...

Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...

April 13 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone, a New ...

Mylan NV finalized a $465 million settlement with the U.S. Justice Department. The settlement resolves claims the pharmaceutical company overcharged the government for its EpiPen emergency allergy ...

Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...